{
    "clinical_study": {
        "@rank": "106074", 
        "arm_group": [
            {
                "arm_group_label": "Dexmedetomidine group", 
                "arm_group_type": "Experimental", 
                "description": "Infusion of dexmedetomidine(0.8\u03bcg/kg) at10 minutes before anesthesia induction.\nInfusion of dexmedetomidine at 0.4 \u03bcg\u2022kg-1\u2022h-1during anesthesia  maintenance.\nThe infusion rate of dexmedetomidine  was reduced to 0.1 \u03bcg\u2022kg-1\u2022h-1 for awaken test."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Infusion normal saline(0.8\u03bcg/kg) at 10 minutes before anesthesia induction.\nInfusion normal saline at 0.4 \u03bcg\u2022kg-1\u2022h-1 during anesthesia  maintenance.\nThe infusion rate of normal saline   was reduced to 0.1 \u03bcg\u2022kg-1\u2022h-1 for awaken test."
            }
        ], 
        "brief_summary": {
            "textblock": "The study designed to explore  the efficacy and safety of the closed loop of target\n      controlled infusion dexmedetomidine combined with propofol for anesthesia with\n      intraoperative wake up."
        }, 
        "brief_title": "The Closed Loop of Target Controlled Infusion Dexmedetomidine Combined With Propofol for Anesthesia With Intraoperative Wake up", 
        "condition": "Anesthesia; Reaction", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Written informed consent.\n\n          -  Ongoing brain functional area surgery with intraoperative wake up.\n\n          -  American Society of Anesthesiologists class I to II.\n\n          -  Aged between 18 and 65 years old.\n\n          -  Weight between plus or minus 20% of the standard weight. Male: (height cm - 80) \u00d7 70%\n             = standard weight Female: (height cm - 70) \u00d7 60% = standard weight\n\n        Exclusion Criteria:\n\n          -  History of hypertension.\n\n          -  Serious heart,brain,liver,kidney, pulmonary, and endocrine disease or serious\n             infection.\n\n          -  Mental disability or mental disease.\n\n          -  Use of sedative drug.\n\n          -  Suspected or confirmed long term use of narcotic analgesics.\n\n          -  Inability to exchange.\n\n          -  Suspected or confirmed  difficult airway.\n\n          -  Suspected of malignant hyperthermia.\n\n          -  Neuromuscular disease.\n\n          -  Allergic to investigational products or with other contraindication.\n\n          -  Subjects who are breastfeeding or pregnant.\n\n          -  Participated in other study within 30 days ."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02143362", 
            "org_study_id": "Dex anesthesia"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Dexmedetomidine group", 
                    "Control group"
                ], 
                "description": "Target Controlled Infusion  propofol  and  remifentanil to  targeted plasma concentrations are  4 \u03bcg/ ml and 4 ng/ml respectively.\nIntermittent injection cisatracurium (0.15mg/kg).\nA laryngeal mask airway  will be placed when bispectral electroencephalogram index is reduced to 60.", 
                "intervention_name": "Anesthesia induction,propofol, remifentanil ,cisatracurium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Dexmedetomidine group", 
                    "Control group"
                ], 
                "description": "Closed-loop target controlled infusion of propofol ,Bispectral electroencephalogram index feedback value will be set at  50.\nTarget Controlled Infusion  remifentanil , targeted plasma concentrations are  3~6ng/ml ,maintain heart rate to 60~100 beats per minute and  mean blood pressure to 70~105 mmHg.\nIntermittent injection cisatracurium (0.05mg/kg).", 
                "intervention_name": "Anesthesia  maintenance , propofol,remifentanil,cisatracurium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Dexmedetomidine group", 
                    "Control group"
                ], 
                "description": "Stopped  Closed-loop target controlled infusion of cisatracurium and propofol  30 minutes before awaken test.\nIn dexmedetomidine group,dexmedetomidine infusion rate will be reduced to 0.1 \u03bcg\u2022kg-1\u2022h-1. In control group ,normal saline infusion will be given with the same infusion rate as dexmedetomidine group .\nCall patients' name and require them to move  both feet every 30 seconds after patients recovered normal respiration.\nPatients will be considered  to be awake when  recover normal respiration  and make  responsive to verbal commands correctly .\nPatients will receive initial  anesthesia after finish awaken test.", 
                "intervention_name": "Awaken test", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Propofol", 
                "Remifentanil", 
                "Dexmedetomidine", 
                "Atracurium", 
                "Cisatracurium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Intraoperative wake up", 
            "Closed loop of target controlled infusion", 
            "Dexmedetomidine", 
            "Propofol"
        ], 
        "lastchanged_date": "May 20, 2014", 
        "number_of_arms": "2", 
        "official_title": "The Closed Loop of Target Controlled Infusion Dexmedetomidine Combined With Propofol for Anesthesia With Intraoperative Wake Up-single Center,Random,Controlled Trial", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Success rate of  awaken test", 
                "safety_issue": "No", 
                "time_frame": "The whole time of surgery,about 8 hours"
            }, 
            {
                "measure": "The time from starting to awaken test to patient wakes up", 
                "safety_issue": "No", 
                "time_frame": "From starting to awaken test to patient wakes up,about 3 hours"
            }, 
            {
                "measure": "Blood sugar concentration", 
                "safety_issue": "No", 
                "time_frame": "30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test"
            }, 
            {
                "measure": "Cortisol  concentration", 
                "safety_issue": "No", 
                "time_frame": "30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test"
            }, 
            {
                "measure": "Epinephrine concentration", 
                "safety_issue": "No", 
                "time_frame": "30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test"
            }, 
            {
                "measure": "Norepinephrine concentration", 
                "safety_issue": "No", 
                "time_frame": "30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment 30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02143362"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "The duration of anesthesia from baseline to patient wake up", 
                "safety_issue": "No", 
                "time_frame": "From baseline to patient wake up ,about 3 hours"
            }, 
            {
                "measure": "The dosage of Cisatracurium before patient wakes up", 
                "safety_issue": "No", 
                "time_frame": "From starting to awaken test to patient wakes up,about 3 hours"
            }, 
            {
                "measure": "The dosage of propofol before patient wakes up", 
                "safety_issue": "No", 
                "time_frame": "From starting to awaken test to patient wakes up,about 3 hours"
            }, 
            {
                "measure": "The dosage of remifentanil before patient wakes up", 
                "safety_issue": "No", 
                "time_frame": "From starting to awaken test to patient wakes up,about 3 hours"
            }, 
            {
                "measure": "Heart rate", 
                "safety_issue": "No", 
                "time_frame": "30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test"
            }, 
            {
                "measure": "Mean arterial pressure", 
                "safety_issue": "No", 
                "time_frame": "30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test"
            }, 
            {
                "measure": "Bispectral electroencephalogram index", 
                "safety_issue": "No", 
                "time_frame": "30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test"
            }
        ], 
        "source": "Second Affiliated Hospital of Xi'an Jiaotong University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Second Affiliated Hospital of Xi'an Jiaotong University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}